Avastin bevacizumab  regulatory update

FDA granted accelerated approval to an sBLA from Genentech for Avastin bevacizumab plus paclitaxel to treat chemotherapy-naive patients with metastatic breast cancer. In December, FDA's Oncologic Drug...